1
TÍTULO: A multicenter, observational, phase 4 study (STELLAR) to evaluate the safety and tolerability of lenvatinib (LEN) in patients with advanced or unresectable hepatocellular carcinoma (uHCC)
AUTORES: Peck Radosavljevic, Markus; Goyal, Lipika; Strasser, Simone; Matilla Pena, Ana Maria; Marinho, Rui; Granito, Alessandro; Roderburg, Christoph; Marsico, Mark; Christou, Vanessa C.; Xie, Ran; Saraf, Pankhoori; Meyer, Tim;
PUBLICAÇÃO: 2022, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 40, NÚMERO: 4
INDEXADO EM: WOS